Arix Bioscience plc Notice of Results

 
TIDMARIX 
 
Arix Bioscience plc 
 
                           Notice of Interim Results 
 
LONDON, 13 August 2020: Arix Bioscience plc ("Arix" or the "Company") (LSE: 
ARIX), a global venture capital company focused on investing in and building 
breakthrough biotech companies, will announce its interim results for the six 
months ended 30 June 2020, on Tuesday 8 September 2020. 
 
Arix will publish a pre-recorded presentation on the same day, at 7.00am BST, 
followed by a Q&A session accessible via conference call or webcast at 12.30pm 
BST. The webcast of the presentation will be available on the Company's 
investor relations website at  https://arixbioscience.com/investor-relations/ 
results-centre. 
 
[ENDS] 
 
Enquiries 
 
For more information on Arix, please contact: 
 
Arix Bioscience plc 
Charlotte Parry, Head of Investor Relations 
[phone] 
[e-mail] 
 
Optimum Strategic Communications 
Mary Clark, Supriya Mathur, Shabnam Bashir 
T: [phone] 
[e-mail] 
 
About Arix Bioscience plc 
 
Arix Bioscience plc is a global venture capital company focused on investing in 
and building breakthrough biotech companies around cutting edge advances in 
life sciences. 
 
We collaborate with exceptional entrepreneurs and provide the capital, 
expertise and global networks to help accelerate their ideas into important new 
treatments for patients. As a listed company, we are able to bring this 
exciting growth phase of our industry to a broader range of investors. 
 
 
 
END 
 

(END) Dow Jones Newswires

August 13, 2020 02:07 ET (06:07 GMT)